Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Acutaas Chemicals Ltd

NSE: ACUTAAS · BSE: 543349 · Pharmaceuticals & Biotechnology · 38 announcements

Share price
₹3,168.60
Market cap
₹25,942 Cr
Revenue (annual)
₹1,339 Cr
Net profit (annual)
₹356.3 Cr
P/E (TTM)
67.2×Sector 47.4×
Promoter holding
32.66%+0.00% QoQ
FII holding
21.61%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

11:36 IST BSE
Regulatory Approval

Acutaas Chemicals Regulatory Approval

Acutaas Chemicals received approval for incentives under the Electronics Components Manufacturing Scheme. The company expects benefits of 25% on an eligible investment of ₹119.12 Crore.

Value
₹119.1 Cr
Execution
5 Years